US Treasury to consult with insurance regulators on private credit lenders, sources say

The US Treasury will convene domestic and international insurance regulators in the coming weeks — the first meeting could be announced as soon as April 1 — to discuss recent jitters in the US$2 trillion non-bank private credit market. Treasury Secretary Scott Bessent is planning sustained Q2 2026 consultations to evaluate fund-level leverage, consistency of private credit ratings, use of offshore reinsurance and liquidity, and to assess transmission risks to regulated institutions (pension funds, banks, captive insurers). Any policy measures would follow these fact-finding sessions, with the Treasury serving as a convening authority rather than a direct insurance regulator.

Analysis

Regulatory attention toward non-bank lending creates a liquidity and valuation shock pathway rather than a pure credit-loss event: opaque NAVs and fund-level leverage make private credit assets highly sensitive to forced re-pricing once a handful of large institutional holders (insurers, pensions, captives) start to rebalance. In practice this can compress bid-offer spreads and produce spot NAV markdowns of 5-15% over a 3–6 month window even if underlying loan defaults remain low, because buyers require liquidity and transparency premia that private managers don’t currently price in.

The primary beneficiaries are capital-rich intermediaries and managers that can provide explicit warehouse/bridge financing or who already disclose granular private-credit metrics; they can capture spread and fee upside as distressed sellers look for immediate exits. Conversely, highly levered BDCs, smaller insurers with concentrated allocations, and boutique private lenders that rely on short-term wholesale funding are most exposed to a fire-sale dynamic — their cost of capital rises and the marginal buyer pool shrinks, exacerbating mark-to-market losses.

Key catalysts to watch over days→months: public NAIC/regulatory guidance, rating-agency uniformity on private-credit scoring, large insurer liquidity disclosures, and any facility or backstop from big banks or central counterparties. A constructive reversal would come from rapid standardization of reporting and an announced liquidity backstop or expanded bank warehousing capacity; absent that, expect volatility and selective derisking across balance sheets for 6–12 months.

Key Decisions for Investors

• Long KKR (KKR) and Ares Management (ARES) on 6–18 month horizon — buy stock or buy 12–18 month call spreads to play fee and deployment advantages; risk: regulatory headwinds could impair fundraising and compress multiple; reward: 20–40% upside if managers pick up distressed flow and grow fee-bearing AUM.
• Short or hedge Ares Capital (ARCC) and similar BDCs over 3–6 months — use puts or buy-in-the-money puts to protect portfolio exposure; risk: unexpected liquidity provision could arrest downside, but expected NAV/discount widening makes this a ~1.5–2x asymmetric payoff if forced sales materialize.
• Pair trade: long large-cap banks (JPM, BAC) vs short smaller non-bank lenders (ARCC) — 3–6 month trade to capture re-intermediation and spread capture as private lenders tap bank warehouses; size to limit downside (stop-loss 6–8% on bank leg) since credit contagion would flip outcome.
• Event-driven: buy Jan 2028 LEAP call spreads on high-quality managers (BLK, BX) ahead of regulatory reporting milestones — low-cost way to capture rerating if transparency standards increase; cap premium paid to preserve >2:1 target upside to downside.